| pubmed-article:14646362 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14646362 | lifeskim:mentions | umls-concept:C0403416 | lld:lifeskim |
| pubmed-article:14646362 | lifeskim:mentions | umls-concept:C0209606 | lld:lifeskim |
| pubmed-article:14646362 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
| pubmed-article:14646362 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
| pubmed-article:14646362 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
| pubmed-article:14646362 | lifeskim:mentions | umls-concept:C1292733 | lld:lifeskim |
| pubmed-article:14646362 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:14646362 | pubmed:dateCreated | 2003-12-3 | lld:pubmed |
| pubmed-article:14646362 | pubmed:abstractText | Integrins are adhesion molecules of fundamental importance to the recruitment of leucocytes in inflammation. The alpha4beta1 integrin (VLA-4) is a leucocyte ligand for endothelial vascular cell adhesion molecule-1 (VCAM-1), fibronectin and osteopontin. We addressed the role of VLA-4 in mediating progressive renal injury in vivo using a blocking monoclonal antibody (mAb) in a rat model of crescentic glomerulonephritis. | lld:pubmed |
| pubmed-article:14646362 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14646362 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14646362 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14646362 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14646362 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14646362 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14646362 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14646362 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14646362 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14646362 | pubmed:issn | 1660-2129 | lld:pubmed |
| pubmed-article:14646362 | pubmed:author | pubmed-author:SmithJennifer... | lld:pubmed |
| pubmed-article:14646362 | pubmed:author | pubmed-author:CookH... | lld:pubmed |
| pubmed-article:14646362 | pubmed:author | pubmed-author:PuseyCharles... | lld:pubmed |
| pubmed-article:14646362 | pubmed:author | pubmed-author:LobbRoy RRR | lld:pubmed |
| pubmed-article:14646362 | pubmed:author | pubmed-author:KhanSarah BSB | lld:pubmed |
| pubmed-article:14646362 | pubmed:author | pubmed-author:BhangalGurjee... | lld:pubmed |
| pubmed-article:14646362 | pubmed:author | pubmed-author:AllenAndrew... | lld:pubmed |
| pubmed-article:14646362 | pubmed:copyrightInfo | Copyright 2003 S. Karger AG, Basel | lld:pubmed |
| pubmed-article:14646362 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:14646362 | pubmed:volume | 95 | lld:pubmed |
| pubmed-article:14646362 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14646362 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14646362 | pubmed:pagination | e100-10 | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:meshHeading | pubmed-meshheading:14646362... | lld:pubmed |
| pubmed-article:14646362 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14646362 | pubmed:articleTitle | Blocking VLA-4 prevents progression of experimental crescentic glomerulonephritis. | lld:pubmed |
| pubmed-article:14646362 | pubmed:affiliation | Renal Section, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, UK. s.khan@imperial.ac.uk | lld:pubmed |
| pubmed-article:14646362 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:16401 | entrezgene:pubmed | pubmed-article:14646362 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:14646362 | lld:entrezgene |
